Evrofarma S.A. (EVROF)
ASE
Closed
Oct 6, 2026
Day's Range
3.8052 wk Range
2.38Overview - EVROF - Evrofarma S.A.
Key Statistics
Valuation
Enterprise Value
65.66M
P/E (Trailing)
‪49.36‬
Price / Sales (TTM)
‪1.03‬
Price / Book
‪2.29‬
EV / EBITDA
‪8.73‬
Profitability
Profit Margin
‪8.38%‬
Operating Margin
‪12.33%‬
Return on Assets
‪5.37%‬
Return on Equity
‪20.16%‬
Ownership
Shares Outstanding
13.64M
Float
3.41M
Held by Insiders
‪72.73%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.70‬
50-Day Avg
‪3.94‬
200-Day Avg
‪3.77‬
Market Cap - EVROF - Evrofarma S.A.
Peers - EVROF - Evrofarma S.A.
Peer Comparison
Compared with companies in Packaged Foods listed on ASE.
Profile Summary - EVROF - Evrofarma S.A.
About
Evrofarma S.A. is a pharmaceutical company involved in the development, production, and commercialization of a wide array of healthcare products. The core purpose of the firm is to deliver high-quality pharmaceuticals primarily aimed at enhancing healthcare outcomes in the regions it serves. Notably, Evrofarma S.A. is…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
